Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
The scientific communication platform (SCP) forms the core for all communications about a product and serves as the repository of available evidence and statements to support Medical Affairs strategy. View this Webinar on Converting Challenges Into Opportunities While Building Your SCP to learn about the following:
In this session, you will hear “insider tips” from three senior-level Medical Affairs leaders from leading multinational biopharma companies. The discussion will be broken into three practical sections:
1. How to advance your career in Medical Affairs;
2. What employers look for when hiring;
3. Competencies required for a modern Medical Affairs organization.
At the conclusion of this session, participants should:
MA has seen an exponential growth over the last decade as it value and place within the pharmaceutical industry is being realised. The evolution of MA from a support function to strategic partner has changed the direction of MA and also required an evolution of skill sets for the roles which underpin MA.
As a profession, there is still a void with a globally recognised advanced scientific qualification, capability frameworks across the main 3 role types and accreditation.
This collaborative webinar aims to discuss available postgraduate courses and insights from alumni into how their qualification helped advance their understanding of pharmaceutical medicine and their career.
The Medical Affairs teams demonstrate leadership and value each year through the annual strategic planning process that aligns all multifunctional MA competencies on common objectives needed to support the product and organization. A focused and cohesive medical strategy must be developed to navigate the complex therapeutic environment for each product – overcoming challenges, taking advantage of opportunities and filling any scientific or clinical gaps. A comprehensive and supportive tactical plan aligned to the medical strategy should define the activities that will provide the most impact and benefit to stakeholders in therapeutic space while taking the MA team one-step closer to achieving annual goals.
The MAPS Medical Affairs Strategic Planning Guide and Template has been developed to provide guidance and recommendations to selected components that comprise the strategic medical affairs planning for a product – including the situational analysis, medical strategy, tactical/operational planning, and medical plan summary.
Understand the latest technologies—Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), and Natural Language Understanding (NLU). Understand the potential of these technologies to increase efficiencies, enhance effectiveness and potentially reduce compliance risk.
At the conclusion of this session, participants should:
• Better understand contemporary digital trends of Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), and Natural Language Understanding (NLU)
As HCP reliance upon digital and social channels as both a source of educational information and a central meeting place for peer-to-peer interaction continues to increase, it’s critical for Medical Affairs teams to monitor that activity, understand who the Digital Opinion Leaders (DOLs) are and engage them appropriately.
In this session we will provide perspectives on the evolving role of Digital Opinion Leaders in medical education and share approaches for identifying, monitoring and engaging them in a compliant manor with relevant examples.
This series will provide you with tools to critically process and analyze medical scientific literature. You will get a good understanding of basic statistical concepts and theory that enable you to explain, understand and interpret data. These Webinars are practical and based on published articles and the analysis of these. You will work with the theory in practice to increase your understanding of the strengths and weaknesses of the statistics in scientific literature.
Statistical analysis in clinical trials
– Null/alternative hypotheses
– Statistical assumptions (type I error, significance level, type II error, statistical power,)
– Hypothesis testing
– Statistical tests
Statistics used in RCTs
– Type of outcome measures (dichotomous, continuous, time-to-event)
– Statistics used for analysis of dichotomous data (relative risk, odds ratio, risk difference, NNT)
– Analysis of time-to-event variables (plotting and interpretation of Kaplan-Meier curves)
Early Access includes a variety of programs by which pharmaceutical companies make investigational therapies available to patients with life-threatening diseases. These patients have either exhausted available treatments or have no approved options. This presentation will review the processes and procedures to consider in the implementation of an Early Access Program and explore the opportunities and challenges posed therein.
At the end of this webinar the participant will be able to:
At the conclusion of this eCademy Webinar, participants will be better able to understand:
As healthcare continues to transform, we need to stay connected to our customers in many ways. From Upstream scientific exchange driving research, to clinical trial design establishing evidence, to co-creation workshops establishing value propositions, to education and post-release support to drive adoption, collaboration with customers across the solution lifecycle is key to providing the best solutions to our customers. MSLs are becoming more important and playing key roles across the lifecycle in partnership with many others who play important roles. We will describe the landscape, drivers, and opportunities for engaging with customers across the lifecycle and how we socialize learnings across the organization.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.